Close
Back to MIST Stock Lookup

(MIST) – Hot FDA News

Dec 26, 2023 07:03 AM Milestone Pharmaceuticals Inc. (MIST) Receives Refusal to File Letter from FDA for NDA for Etripamil
Nov 7, 2022 12:13 PM Milestone Pharmaceuticals (MIST) Announces New Data from Phase 3 RAPID Trial of Etripamil Nasal Spray in Patients with PSVT During Late-Breaking Session at the AHA
Oct 17, 2022 07:13 AM

Back to MIST Stock Lookup